Pneumonia News and Research

Latest Pneumonia News and Research

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Reduced cognitive efficacy and cardiovascular changes in patients post-COVID-19 recovery

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

COVID-19 severity is correlated with body composition

COVID-19 severity is correlated with body composition

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Study suggests history of childhood traumas may increase the risk of long COVID

Study suggests history of childhood traumas may increase the risk of long COVID

SARS-CoV-2 viroporins mediate cytokine storm via mitochondrial permeability transition pore

SARS-CoV-2 viroporins mediate cytokine storm via mitochondrial permeability transition pore

Why pregnant people were left behind while vaccines moved at ‘warp speed’ to help the masses

Why pregnant people were left behind while vaccines moved at ‘warp speed’ to help the masses

Pulmonary dysfunction in pediatric patients after acute COVID-19 infection

Pulmonary dysfunction in pediatric patients after acute COVID-19 infection

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

SARS-Cov-2 reinfection in Syrian hamsters does not result in disease

SARS-Cov-2 reinfection in Syrian hamsters does not result in disease

Lung microbiome alterations and secondary-infections in lethal COVID-19

Lung microbiome alterations and secondary-infections in lethal COVID-19

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.